EDAP EDAP TMS SA

Nasdaq edap-tms.com


$ 2.40 $ 0.00 (0 %)    

Thursday, 23-Oct-2025 13:12:02 EDT
QQQ $ 610.76 $ 0.00 (0 %)
DIA $ 467.80 $ 0.00 (0 %)
SPY $ 672.38 $ 0.00 (0 %)
TLT $ 91.60 $ 0.00 (0 %)
GLD $ 380.63 $ 0.00 (0 %)
$ 2.32
$ 2.34
$ 2.35 x 1,050
$ 2.43 x 100
$ 2.34 - $ 2.40
$ 1.21 - $ 3.08
55,671
na
86.75M
$ 0.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 edap-tms-says-french-ministry-of-health-awarded-reimbursement-for-high-intensity-focused-ultrasound-procedure-for-treatment-of-prostate-cancer-in-france

Focal One Robotic HIFU procedure now covered under France's national universal health system Reimbursement milestone allows...

 edap-tms-updates-its-fiscal-2025-hifu-yoy-revenue-growth-guidance-range-to-26-34-vs-prior-range-of-16-25

The Company is updating its 2025 financial guidance. Core HIFU business revenue is now expected to grow within the range of 26%...

 edap-tms-will-no-longer-qualify-as-foreign-issuer-adopts-us-reporting-rules

EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, annou...

 edap-tms-q1-eps-020-misses-015-estimate-sales-1428m-miss-1490m-estimate

Edap TMS (NASDAQ:EDAP) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.15) by...

 edap-tms-final-results-of-farp-study-achieves-primary-endpoint-confirms-non-inferiority-of-focal-ablation-vs-radical-prostatectomy-at-36-month-follow-up

Final 3-year outcome of Focal Ablation versus Radical Prostatectomy (FARP) Randomized Controlled Trial (RCT) presented at 120th...

 edap-announces-launch-of-new-focal-one-i-robotic-hifu-system-at-upcoming-120th-american-urological-association-annual-meeting-april-26-29-in-las-vegas-nevada

Focal One i expands HIFUsion® patient-specific imaging compatibility to include PSMA PET, ExactVu™ Micro-Ultrasound, along with...

 jefferies-downgrades-edap-tms-to-hold-lowers-price-target-to-2

Jefferies analyst Michael Sarcone downgrades Edap TMS (NASDAQ:EDAP) from Buy to Hold and lowers the price target from $8 to $2.

 piper-sandler-maintains-overweight-on-edap-tms-lowers-price-target-to-45

Piper Sandler analyst Jason Bednar maintains Edap TMS (NASDAQ:EDAP) with a Overweight and lowers the price target from $5 to...

 hc-wainwright--co-reiterates-buy-on-edap-tms-maintains-19-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Edap TMS (NASDAQ:EDAP) with a Buy and maintains $19 price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION